Abstract
The recent publication of the interim report of the PHARMAC Review Panel raises important questions of the role and processes of PHARMAC in securing equitable access to pharmaceuticals for all New Zealanders.
| Original language | English |
|---|---|
| Pages (from-to) | 170-177 |
| Number of pages | 8 |
| Journal | New Zealand Medical Journal |
| Volume | 135 |
| Issue number | 1550 |
| Publication status | Published - 25 Feb 2022 |
| Externally published | Yes |